The effect of Vit D on AMH level and ovarian reserve in 18-40 years old female breast cancer patients who have been treated with chemotherapy between 1397-1398 in Imam Khomeini hospital.

The effect of Vit D on AMH level and ovarian reserve in female breast cancer patients who have been treated with chemotherapy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180718040514N1

Enrollment

Registered

2019-03-12

Start date

2018-11-27

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility due to breast cancer chemotherapy..

Interventions

Intervention 1: In this study 18-40 years old female breast cancer patients will be randomized in 2 groups. patients with history of cytotoxic therapy or BSO will be excluded.age,number of pregnancie

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Chemotherapy candidate Breast cancer patients between 18-40 years- old.

Exclusion criteria

Exclusion criteria: History of cytotoxic treatment GNRH agonist treatment during or after chemotherapy EF<50% Positive history for BSO(bilateral salpingo-oophorectomy)

Design outcomes

Primary

Measure	Time frame
AMH level before ,immediately after and 6 month after chemotherapy. Timepoint: Before chemotherapy , immediately after chemotherapy and 6 month after end of chemotherapy. Method of measurement: ELISA technique in central Imam Khomeini laboratory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Dastmardi

Tehran University of Medical Sciences

zahradastmardi@yahoo.com+98 21 6119 2567

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026